Journal
THROMBOSIS AND HAEMOSTASIS
Volume 122, Issue 3, Pages 329-335Publisher
GEORG THIEME VERLAG KG
DOI: 10.1055/a-1715-5960
Keywords
direct oral anticoagulant; surgery; FCSA
Categories
Ask authors/readers for more resources
Patients on anticoagulant treatment often need to temporarily interrupt their medication for surgeries or invasive procedures. The Italian Federation of Centers for the diagnosis of thrombotic disorders and the Surveillance of the Antithrombotic therapies (FCSA) provides practical guidance and expert opinions on assessing risks, testing, using heparin, restarting medication after high-risk bleeding surgery, and nonpharmacological suggestions for perioperative management. FCSA also suggests forming a multidisciplinary anticoagulation team for optimal management.
Patients on anticoagulant treatment are constantly increasing, with an estimated prevalence in Italy of 2% of the total population. About a quarter of the anticoagulated patients require temporary cessation of direct oral anticoagulants (DOACs) or vitamin K antagonists for a planned intervention within 2 years from anticoagulation inception. Several clinical issues about DOAC interruption remain unanswered: many questions are tentatively addressed daily by thousands of physicians worldwide through an experience-based balancing of thrombotic and bleeding risks. Among possible valuable answers, the Italian Federation of Centers for the diagnosis of thrombotic disorders and the Surveillance of the Antithrombotic therapies (FCSA) proposes some experience-based suggestions and expert opinions. In particular, FCSA provides practical guidance on the following issues: (1) multiparametric assessment of thrombotic and bleeding risks based on patients' individual and surgical risk factor, (2) testing of prothrombin time, activated partial thromboplastin time, and DOAC plasma levels before surgery or invasive procedure, (3) use of heparin, (4) restarting of full-dose DOAC after high risk bleeding surgery, (5) practical nonpharmacological suggestions to manage patients perioperatively. Finally, FCSA suggests creating a multidisciplinary anticoagulation team with the aim to define the optimal perioperative management of anticoagulation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available